» Articles » PMID: 3137564

Rapid Induction of IgM-secreting Murine Plasmacytomas by Pristane and an Immunoglobulin Heavy-chain Promoter/enhancer-driven C-myc/v-Ha-ras Retrovirus

Overview
Specialty Science
Date 1988 Aug 1
PMID 3137564
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

A retroviral vector, RIM, containing murine c-myc under the control of immunoglobulin heavy-chain gene promoter and enhancer elements and v-Ha-ras driven by a Moloney murine leukemia virus long terminal repeat induced IgM-secreting plasmacytomas in 28% of adult and 83% of 3-week-old pristane-conditioned mice with mean latency periods of 60-70 days. In contrast, the same vector only harboring c-myc or v-Ha-ras was virtually ineffective. RIM-induced plasmacytomas expressed retroviral myc and ras genes while their endogenous c-myc alleles were unrearranged and transcriptionally inactive. These plasmacytomas were clonal as each possessed a unique immunoglobulin heavy-chain joining region rearrangement and a single recombinant provirus. Moloney murine leukemia helper virus did not play an obligatory role in tumorigenesis since insertions of Moloney murine leukemia proviruses were found in only 6 of 24 plasmacytomas induced in adult mice. Taken together, these findings support the view that the v-Ha-ras oncogene can cooperate with an activated myc gene in pristane plasmacytomagenesis.

Citing Articles

Targeted overexpression of an activated N-ras gene results in B-cell and plasma cell lymphoproliferation and cooperates with c-myc to induce fatal B-cell neoplasia.

Linden M, Kirchhof N, Carlson C, Van Ness B Exp Hematol. 2011; 40(3):216-27.

PMID: 22120021 PMC: 3279594. DOI: 10.1016/j.exphem.2011.11.006.


Gene expression profiling reveals different pathways related to Abl and other genes that cooperate with c-Myc in a model of plasma cell neoplasia.

Park E, Shaughnessy Jr J, Gupta S, Wang H, Lee J, Woo H BMC Genomics. 2007; 8:302.

PMID: 17764563 PMC: 2040348. DOI: 10.1186/1471-2164-8-302.


Efficiency alleles of the Pctr1 modifier locus for plasmacytoma susceptibility.

Zhang S, Dubois W, Ramsay E, Bliskovski V, Morse 3rd H, Taddesse-Heath L Mol Cell Biol. 2000; 21(1):310-8.

PMID: 11113205 PMC: 88804. DOI: 10.1128/MCB.21.1.310-318.2001.


Cdkn2a, the cyclin-dependent kinase inhibitor encoding p16INK4a and p19ARF, is a candidate for the plasmacytoma susceptibility locus, Pctr1.

Zhang S, Ramsay E, Mock B Proc Natl Acad Sci U S A. 1998; 95(5):2429-34.

PMID: 9482902 PMC: 19364. DOI: 10.1073/pnas.95.5.2429.


Selective expression of intracisternal A-particle genes in established mouse plasmacytomas.

Lueders K, FEWELL J, Morozov V, Kuff E Mol Cell Biol. 1993; 13(12):7439-46.

PMID: 8246961 PMC: 364815. DOI: 10.1128/mcb.13.12.7439-7446.1993.


References
1.
Potter M, Hartley J, Wax J, Gallahan D . Effect of MuLV-related genes on plasmacytomagenesis in BALB/c mice. J Exp Med. 1984; 160(2):435-40. PMC: 2187450. DOI: 10.1084/jem.160.2.435. View

2.
Cepko C, Roberts B, Mulligan R . Construction and applications of a highly transmissible murine retrovirus shuttle vector. Cell. 1984; 37(3):1053-62. DOI: 10.1016/0092-8674(84)90440-9. View

3.
Pietrangeli C, OSMOND D . Regulation of B-lymphocyte production in the bone marrow: role of macrophages and the spleen in mediating responses to exogenous agents. Cell Immunol. 1985; 94(1):147-58. DOI: 10.1016/0008-8749(85)90092-9. View

4.
Yang J, Bauer S, MUSHINSKI J, Marcu K . Chromosome translocations clustered 5' of the murine c-myc gene qualitatively affect promoter usage: implications for the site of normal c-myc regulation. EMBO J. 1985; 4(6):1441-7. PMC: 554365. DOI: 10.1002/j.1460-2075.1985.tb03800.x. View

5.
Potter M, Wax J, Blankenhorn E . BALB/c subline differences in susceptibility to plasmacytoma induction. Curr Top Microbiol Immunol. 1985; 122:234-41. DOI: 10.1007/978-3-642-70740-7_33. View